- $1.82bn
- $1.93bn
- $285.50m
- 49
- 30
- 74
- 50
Annual cashflow statement for MannKind, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -57.2 | -80.9 | -87.4 | -11.9 | 27.6 |
| Depreciation | |||||
| Non-Cash Items | 36.7 | 32.7 | 24.7 | 26.9 | 44 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.78 | -17.7 | -24.1 | 14.6 | -36.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -28.1 | -61.7 | -80.7 | 34.1 | 42.5 |
| Capital Expenditures | -4.78 | -11.5 | -7.59 | -42.4 | -9.69 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 20 | -140 | 12.5 | 40.5 | -87 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 15.2 | -152 | 4.87 | -1.99 | -96.6 |
| Financing Cash Flow Items | -0.518 | -17.4 | -1.47 | -5.08 | -0.752 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.9 | 270 | 21.4 | 137 | -137 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36.9 | 57 | -54.4 | 169 | -191 |